CERS Q3 2024 Earnings — Cerus Corporation Revenue & Financial Results | Market Cap Arena

CERSCerus Corporation

$358M

Q3 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$46M+15.7% YoY

Gross Profit

$26M56.9% margin

Operating Income

-$961,000-2.1% margin

Net Income

-$3M-6.4% margin

EPS (Diluted)

$-0.02

QoQ Revenue Growth

+2.1%

Cash Flow

Operating Cash Flow

$4M

Free Cash Flow

$3M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$190M

Total Liabilities

$135M

Stockholders' Equity

$53M

Cash & Equivalents

$22M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$46M	$40M	+15.7%
Gross Profit	$26M	$22M	+20.1%
Operating Income	-$961,000	-$5M	+81.7%
Net Income	-$3M	-$7M	+59.6%

Revenue Segments

Product

$46M91%

Government Contract

$5M9%

Geographic Segments

North America

$32M68%

Europe Middle East And Africa

$14M30%

Other

$696,0002%